FI
FWG Investments, LLC.
13F filer · CIK 0001944877Reported Jul 28, 2026
Net buyer this quarter
13F portfolio value$189MU.S. long equity reported on 13F
Positions376 new · 0 closed
Net flow last quarter+$10.6MBuys minus sells
Top 10 positions weight12.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 28, 202637 positions | |||||
| $6.4M | 3.38% | Not reported | Not reported | Q2 2024 | |
| OBONEZOne Bio, Corp. | $5.16M | 2.73% | Not reported | +112.7% | Q1 2025 |
| $2.33M | 1.23% | Not reported | -6.8% | Q1 2024 | |
| $2.09M | 1.10% | 0.00% | +1.2% | Q1 2024 | |
| $1.5M | 0.79% | Not reported | +5.5% | Q1 2024 | |
| $1.47M | 0.78% | Not reported | -11.2% | Q1 2024 | |
| $1.43M | 0.76% | 0.14% | +1.7% | Q1 2024 | |
| $1.38M | 0.73% | Not reported | +10.8% | Q1 2024 | |
| $897K | 0.47% | Not reported | +35.8% | Q1 2024 | |
| $881K | 0.47% | 0.00% | -14.7% | Q1 2024 | |
| $810K | 0.43% | 0.00% | +1.1% | Q1 2024 | |
| $724K | 0.38% | Not reported | -11.3% | Q1 2024 | |
| $702K | 0.37% | 0.00% | -2.1% | Q1 2024 | |
| $698K | 0.37% | 0.01% | +52.0% | Q3 2025 | |
| $686K | 0.36% | Not reported | +8.0% | Q3 2025 | |
| $677K | 0.36% | 0.20% | -17.0% | Q2 2025 | |
| $650K | 0.34% | 0.00% | +37.1% | Q1 2024 | |
| $638K | 0.34% | 0.00% | -3.9% | Q2 2025 | |
| $608K | 0.32% | Not reported | -0.6% | Q1 2024 | |
| $545K | 0.29% | 0.00% | +1.8% | Q1 2024 | |
| $498K | 0.26% | 0.00% | New | Q2 2026 | |
| $460K | 0.24% | 0.00% | +0.2% | Q1 2024 | |
| $393K | 0.21% | 0.00% | -14.3% | Q1 2026 | |
| $376K | 0.20% | 0.00% | -3.8% | Q2 2024 | |
| $356K | 0.19% | Not reported | +17.8% | Q1 2026 | |
| $350K | 0.19% | 0.00% | +0.2% | Q1 2024 | |
| $341K | 0.18% | 0.00% | -1.4% | Q1 2026 | |
| $330K | 0.17% | 0.00% | -18.8% | Q4 2025 | |
| $319K | 0.17% | Not reported | -1.0% | Q1 2024 | |
| $311K | 0.16% | 0.00% | Not reported | Q1 2024 | |
| $307K | 0.16% | 0.00% | Not reported | Q4 2025 | |
| $265K | 0.14% | 0.00% | New | Q2 2026 | |
| $248K | 0.13% | 0.00% | -1.3% | Q1 2024 | |
| $231K | 0.12% | 0.00% | +6.6% | Q1 2024 | |
| $210K | 0.11% | 0.00% | New | Q2 2026 | |
| $205K | 0.11% | 0.00% | Not reported | Q1 2024 | |
| $205K | 0.11% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported Apr 21, 202631 positions | |||||
| $2.35M | 1.49% | Not reported | -10.7% | Q1 2024 | |
| OBONEZOne Bio, Corp. | $2.2M | 1.40% | Not reported | +1.8% | Q1 2025 |
| $1.81M | 1.15% | 0.00% | +9.3% | Q1 2024 | |
| $1.46M | 0.93% | Not reported | -6.5% | Q1 2024 | |
| $1.31M | 0.83% | 0.14% | +1.2% | Q1 2024 | |
| $1.29M | 0.82% | Not reported | -20.7% | Q1 2024 | |
| $974K | 0.62% | Not reported | +13.4% | Q1 2024 | |
| $899K | 0.57% | 0.00% | +9.2% | Q1 2024 | |
| $819K | 0.52% | Not reported | -11.9% | Q1 2024 | |
| $795K | 0.51% | 0.00% | +17.7% | Q1 2024 | |
| $685K | 0.44% | 0.24% | +29.6% | Q2 2025 | |
| $627K | 0.40% | 0.00% | +30.1% | Q1 2024 | |
| $619K | 0.39% | Not reported | +49.8% | Q1 2024 | |
| $588K | 0.37% | 0.00% | -12.4% | Q1 2024 | |
| $544K | 0.35% | 0.01% | +59.1% | Q3 2025 | |
| $544K | 0.35% | 0.00% | +55.8% | Q2 2025 | |
| $534K | 0.34% | Not reported | +0.1% | Q3 2025 | |
| $532K | 0.34% | Not reported | -4.7% | Q1 2024 | |
| $426K | 0.27% | 0.00% | +78.5% | Q1 2024 | |
| $406K | 0.26% | 0.00% | -5.3% | Q1 2024 | |
| $381K | 0.24% | 0.00% | +25.9% | Q4 2025 | |
| $319K | 0.20% | 0.00% | New | Q1 2026 | |
| $314K | 0.20% | 0.00% | +46.6% | Q2 2024 | |
| $302K | 0.19% | 0.00% | +11.3% | Q1 2024 | |
| $290K | 0.18% | 0.00% | New | Q1 2026 | |
| $282K | 0.18% | 0.00% | -0.1% | Q1 2024 | |
| $265K | 0.17% | Not reported | New | Q1 2026 | |
| $262K | 0.17% | Not reported | -11.0% | Q1 2024 | |
| $240K | 0.15% | 0.00% | Not reported | Q4 2025 | |
| $234K | 0.15% | 0.00% | +11.6% | Q1 2024 | |
| $225K | 0.14% | 0.00% | -19.5% | Q1 2024 | |
| Q4 2025Reported Jan 28, 202633 positions | |||||
| $2.59M | 1.65% | Not reported | -5.7% | Q1 2024 | |
| OBONEZOne Bio, Corp. | $2.24M | 1.43% | Not reported | +3.9% | Q1 2025 |
| $1.77M | 1.13% | 0.00% | +4.3% | Q1 2024 | |
| $1.59M | 1.01% | Not reported | -7.5% | Q1 2024 | |
| $1.51M | 0.96% | Not reported | +1.7% | Q1 2024 | |
| $1.26M | 0.80% | 0.14% | -19.3% | Q1 2024 | |
| $935K | 0.60% | Not reported | -3.8% | Q1 2024 | |
| $914K | 0.58% | Not reported | +5.2% | Q1 2024 | |
| $882K | 0.56% | 0.00% | -8.8% | Q1 2024 | |
| $881K | 0.56% | 0.00% | +14.8% | Q1 2024 | |
| $602K | 0.38% | 0.00% | -6.6% | Q1 2024 | |
| $586K | 0.37% | Not reported | -1.5% | Q1 2024 | |
| $578K | 0.37% | Not reported | +171.8% | Q3 2025 | |
| $563K | 0.36% | 0.18% | +23.7% | Q2 2025 | |
| $534K | 0.34% | 0.00% | -13.2% | Q1 2024 | |
| $518K | 0.33% | 0.00% | +19.9% | Q1 2024 | |
| $430K | 0.27% | 0.00% | +11.2% | Q3 2025 | |
| $401K | 0.26% | Not reported | +4.1% | Q1 2024 | |
| $391K | 0.25% | 0.00% | -4.2% | Q2 2025 | |
| $379K | 0.24% | 0.00% | -5.0% | Q1 2024 | |
| $325K | 0.21% | 0.00% | Not reported | Q1 2024 | |
| $322K | 0.20% | Not reported | -14.7% | Q1 2024 | |
| $313K | 0.20% | 0.00% | +22.6% | Q3 2025 | |
| $285K | 0.18% | 0.00% | -9.6% | Q1 2024 | |
| $265K | 0.17% | 0.00% | New | Q4 2025 | |
| $262K | 0.17% | 0.00% | -14.2% | Q1 2024 | |
| $233K | 0.15% | 0.00% | Not reported | Q2 2024 | |
| $226K | 0.14% | 0.00% | New | Q4 2025 | |
| $219K | 0.14% | 0.00% | -28.2% | Q1 2024 | |
| $216K | 0.14% | 0.00% | -12.3% | Q1 2024 | |
| $201K | 0.13% | 0.00% | -11.5% | Q1 2024 | |
| $201K | 0.13% | Not reported | New | Q4 2025 | |
| $38.6K | 0.02% | 0.00% | +0.7% | Q1 2024 | |
| Q3 2025Reported Oct 29, 202533 positions | |||||
| $2.67M | 1.83% | Not reported | -6.6% | Q1 2024 | |
| OBONEZOne Bio, Corp. | $2.2M | 1.51% | Not reported | +47.2% | Q1 2025 |
| $1.68M | 1.15% | Not reported | +2.4% | Q1 2024 | |
| $1.59M | 1.09% | 0.00% | +2.3% | Q1 2024 | |
| $1.53M | 1.05% | 0.17% | +3.9% | Q1 2024 | |
| $1.47M | 1.01% | Not reported | +4.3% | Q1 2024 | |
| $1.1M | 0.76% | Not reported | +10.4% | Q1 2025 | |
| $1.04M | 0.71% | 0.00% | -3.0% | Q1 2024 | |
| $975K | 0.67% | Not reported | -33.3% | Q1 2024 | |
| $850K | 0.58% | Not reported | +22.2% | Q1 2024 | |
| $768K | 0.53% | 0.00% | -2.1% | Q1 2024 | |
| $596K | 0.41% | 0.00% | +0.9% | Q1 2024 | |
| $585K | 0.40% | 0.00% | -8.0% | Q1 2024 | |
| $581K | 0.40% | Not reported | +10.0% | Q1 2024 | |
| $447K | 0.31% | 0.15% | +22.3% | Q2 2025 | |
| $428K | 0.29% | 0.00% | -5.2% | Q1 2024 | |
| $388K | 0.27% | 0.00% | +2.7% | Q2 2025 | |
| $378K | 0.26% | Not reported | -52.1% | Q1 2024 | |
| $368K | 0.25% | 0.00% | -10.7% | Q1 2024 | |
| $360K | 0.25% | 0.00% | -5.8% | Q1 2024 | |
| $352K | 0.24% | 0.00% | +0.1% | Q1 2024 | |
| $346K | 0.24% | 0.00% | New | Q3 2025 | |
| $320K | 0.22% | 0.00% | -9.4% | Q1 2024 | |
| $298K | 0.20% | 0.00% | +2.7% | Q1 2024 | |
| $293K | 0.20% | Not reported | -15.8% | Q1 2024 | |
| $277K | 0.19% | 0.00% | New | Q3 2025 | |
| $233K | 0.16% | 0.00% | -27.6% | Q1 2024 | |
| $224K | 0.15% | Not reported | New | Q3 2025 | |
| $217K | 0.15% | 0.00% | New | Q3 2025 | |
| $212K | 0.15% | 0.00% | -21.2% | Q1 2024 | |
| $203K | 0.14% | 0.00% | -6.4% | Q1 2024 | |
| $66.1K | 0.05% | 0.00% | New | Q3 2025 | |
| $40.7K | 0.03% | 0.00% | -47.0% | Q1 2024 | |
Premium opens every quarter this fund has filed